₹0.85
(Market cap
₹607 Cr
Revenue (TTM)
₹47 Cr
P/E Ratio
131.4
P/B Ratio
18.1
Div. Yield
0 %
Quality Score
8/10
Growth Score
5/10
Valuation Score
7/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
30.5 %
-
ROCE
30 %
-
Industry P/E
47.89
-
EV/EBITDA
80.8
-
Debt to Equity
0.3
-
Book Value
₹13.6
-
EPS
₹2.7
-
Face value
10
-
Shares outstanding
17,150,000
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aptus Pharma
| 422.3 | 21.9 | 57.6 | -- | -- | -- | -- |
|
BSE Healthcare
| 20.1 | 3.2 | 8.1 | 16.5 | 23.4 | 14.6 | 12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aptus Pharma
|
354.1 | 607.3 | 46.6 | 4.6 | -- | 30.5 | 131.4 | 18.1 |
| 3,265.2 | 26,763.3 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.3 | 15.5 | |
| 844.4 | 16,595.8 | 7,784.0 | 688.5 | 10.6 | 14 | 23.9 | 2.8 | |
| 461.5 | 17,658.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 166.2 | 4.6 | |
| 860.3 | 23,459.1 | 5,632.3 | 662.4 | 17.2 | 14.3 | 35.4 | 4.8 | |
| 1,058.0 | 16,861.5 | 8,608.3 | 351.6 | 8.7 | 5.7 | 47.9 | 2.4 | |
| 1,596.7 | 18,321.3 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.1 | |
| 210.7 | 28,044.9 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.5 | |
| 1,674.8 | 27,712.5 | 1,935.8 | 288.2 | 20.6 | 29.8 | 96.2 | 20.6 | |
| 2,329.7 | 37,857.4 | 3,564.0 | 414.0 | 15.3 | 8.4 | 92.6 | 7.5 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Aptus Pharma
--
-
Incorporated
2010
-
Chairman
--
-
Managing Director
Tejash Maheshchandra Hathi
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Aptus Pharma Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Aptus Pharma
What is the current share price of Aptus Pharma Ltd Today?
The share price of Aptus Pharma Ltd is ₹354.10 (BSE) as of 23-Sep-2026 IST. Aptus Pharma Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Aptus Pharma Ltd?
The P/E ratio of Aptus Pharma Ltd is 131.45 times as on 23-Sep-2026, a 174 premium to its peers’ median range of 47.89 times.
The P/B ratio of Aptus Pharma Ltd is 18.05 times as on 23-Sep-2026, a 256 premium to its peers’ median range of 5.07 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
20.74 |
10.26 |
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2026 |
20.74 |
10.26 |
What is the 52 Week High and Low of Aptus Pharma Ltd?
The 52-week high and low of Aptus Pharma Ltd are Rs 365.50 and Rs 32.32 as of 24-Sep-2026.
What is the market cap of Aptus Pharma Ltd?
Aptus Pharma Ltd has a market capitalisation of ₹ 607 Cr as on 23-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Aptus Pharma Ltd?
Before investing in Aptus Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.